- Teva launches generic drug for cystic fibrosis patients
- NACDS, NCPA, GPhA express support for Drug Quality and Security Act
- Teva launches imiquimod cream
- Teva launches authorized generic version of Pfizer's Detrol LA
- Generic drug prices spike, but PBMs' reimbursement rates don't keep up, NCPA study finds
NORTH WALES, Pa. Teva Pharmaceuticals has launched a generic treatment for epileptic seizures.
The world’s largest generic drug maker announced Wednesday the launch of diazepam rectal gel, a generic version of Valeant Pharmaceuticals’ Diastat AcuDial. The drug is administered via rectal syringe and is available in 2.5-mg, 10-mg and 20-mg strengths.
“Generic pharmaceuticals are playing an increasingly important role in healthcare cost containment,” Teva VP customer operations and marketing Maureen Cavanaugh said. “Teva Pharmaceuticals continues to lead the way with timely new product launches.”